BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10522656)

  • 1. Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.
    Merrill RM; Feuer EJ; Warren JL; Schussler N; Stephenson RA
    Am J Epidemiol; 1999 Oct; 150(8):848-60. PubMed ID: 10522656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate.
    Merrill RM; Wiggins CL
    Urol Oncol; 2002; 7(5):213-9. PubMed ID: 12644219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diminishing role of transurethral resection of the prostate.
    Merrill RM; Hunter BD
    Ann Surg Oncol; 2010 May; 17(5):1422-8. PubMed ID: 20091426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy.
    Endrizzi J; Optenberg S; Byers R; Thompson IM
    Urology; 2001 Apr; 57(4):733-6. PubMed ID: 11306392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?
    Lee LS; Thiruneelakandasivam S; Hong MK; Peters JS; Warren A; Mills R; Greenberg D; Wright K; Gnanapragasam V
    Urol Int; 2013; 91(4):397-403. PubMed ID: 23921216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer trends in Canada: rising incidence or increased detection?
    Levy IG; Gibbons L; Collins JP; Perkins DG; Mao Y
    CMAJ; 1993 Sep; 149(5):617-24. PubMed ID: 8364818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising incidence of prostate cancer in Scotland: increased risk or increased detection?
    Brewster DH; Fraser LA; Harris V; Black RJ
    BJU Int; 2000 Mar; 85(4):463-72; discussion 472-3. PubMed ID: 10691826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
    Jones JS; Follis HW; Johnson JR
    Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
    Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
    Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Incidence of Incidental Prostate Cancer in Transurethral Resection of Prostate Specimens in China. The Value of Pathologic Review.
    Lin J; Yu X; Yang X; Jin J; Zhou L; Liu L; Su J; Li Y; Shang M
    Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):31-7. PubMed ID: 27363064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative symptoms predict continence after post-radiation transurethral resection of prostate.
    Polland A; Vertosick EA; Sjoberg DD; Stearns GL; Leddy LS; Kollmeier MA; Sandhu JS
    Can J Urol; 2017 Aug; 24(4):8903-8909. PubMed ID: 28832309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.
    Crain DS; Amling CL; Kane CJ
    J Urol; 2004 Feb; 171(2 Pt 1):668-71. PubMed ID: 14713783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous transurethral resection of prostate and prostate needle biopsy in patients with acute urinary retention and elevated prostate specific antigen levels.
    Chen YT; Chiang PH; Hsu CC
    Chang Gung Med J; 2009; 32(4):417-22. PubMed ID: 19664348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
    Bright EA; Manuel C; Goddard JC; Khan MA
    Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer.
    Krupski TL; Stukenborg GJ; Moon K; Theodorescu D
    BJU Int; 2010 Nov; 106(10):1477-83. PubMed ID: 20977594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
    J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.